Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Distribution of Infectious Complications Following CLL1 CAR-T Cell Therapy for R/R AML: A Single-Center Experience

Jianmei Xu, Huan Zhang, Yifan Zhao, Xiaomei Zhang, Shujing Guo, Hairong Lv, Xia Xiao, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 6018.

https://doi.org/10.1182/blood-2024-202265

Published: 2024

Journal Articles

Development of ThisCART371 Targeting CLL1 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Xiaomei Zhang, Xia Xiao, Hairong Lv, Xue Bai, Pengjiang Liu, Yedi Pu, Juanxia Meng, Haibo Zhu, Zhao Wang, Huan Zhang, Xiaoyuan He, Yu Zhang, Cuicui Lv, Yifan Zhao, Shujing Guo, Jile Liu, Mohan Zhao, Jun Li, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 7210.

https://doi.org/10.1182/blood-2024-204381

Published: 2024

Journal Articles

Efficacy and Safety of CAR-T Therapy Targeting CLL1 in Patients with Extramedullary Diseases of Acute Myeloid Leukemia

Yifan Zhao, Xue Bai, Shujing Guo, Xiaomei Zhang, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 2082.

https://doi.org/10.1182/blood-2024-205229

Published: 2024

Journal Articles

Variables Associated with Outcomes in Patients with Chronic Neutrophilic Leukemia with CSF3R T618I : A Multi-Centre Retrospective Study

Blood (2024) 144 (Supplement 1): 1793.

https://doi.org/10.1182/blood-2024-207591

Published: 2024

Journal Articles

Modified Dual CLL1-CD15 and CLL1-CD16 Icar-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia

Rui Zhang, Yifan Zhao, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 372.

https://doi.org/10.1182/blood-2024-205192

Published: 2024

Journal Articles

CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study

Jinglei Yu, Fengmei Song, Mingming Zhang, Mingfeng Zhao, Wei Sang, Songfu Jiang, Lixin Wang, Xingbing Wang, He Huang, Yongxian Hu, Guoqing Wei

Blood (2024) 144 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2024-210616

Published: 2024

Journal Articles

Oncolytic Herpes Simplex Virus-Loaded CD19 CAR-T Cells Improves the Therapeutic Effect of Diffuse Large B-Cell Lymphoma

Jile Liu, Xiaomei Zhang, Rui Sun, Shujing Guo, Yuxin An, Yifan Zhao, Mohan Zhao, Hongkai Zhang, Mingfeng Zhao

Blood (2024) 144 (Supplement 1): 4810.

https://doi.org/10.1182/blood-2024-205138

Published: 2024

Journal Articles

Split CAR-T Cells Targeting CD312 and TIM-3 for AML to Reduce the Risk of Antigen Escape

Xiao Chai, Xiaomei Zhang, Mingfeng Zhao, Rui Zhang

Blood (2024) 144 (Supplement 1): 4795.

https://doi.org/10.1182/blood-2024-206777

Published: 2024

Journal Articles

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 2100.

https://doi.org/10.1182/blood-2023-173926

Published: 2023

Journal Articles

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Blood (2023) 142 (Supplement 1): 2106.

https://doi.org/10.1182/blood-2023-180387

Published: 2023

Journal Articles

Evaluating the Effectiveness of Risk Adjustment Using Dynamic Frailty Assessment in Treating Newly Diagnosed Multiple Myeloma in Elderly Patients

Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Mingjie Tian, Luoming Hua, Mingfeng Zhao

Blood (2023) 142 (Supplement 1): 6644.

https://doi.org/10.1182/blood-2023-185684

Published: 2023

Journal Articles

Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma

Jianmei Xu, Hua Xue, Songying Zhao, Jing Wang, Huimei Guo, Jiangbo Zhang, Jia Liu, Luoming Hua, Mingjie Tian, Mingfeng Zhao

Blood (2023) 142 (Supplement 1): 6690.

https://doi.org/10.1182/blood-2023-185230

Published: 2023

Journal Articles

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Blood (2022) 139 (23): 3376–3386.

https://doi.org/10.1182/blood.2021013733

Published: 2022

Includes: Supplemental data

Journal Articles

CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL

Blood (2020) 136 (Supplement 1): 48.

https://doi.org/10.1182/blood-2020-140431

Published: 2020

Journal Articles

Low-Dose Decitabine Plus Venetoclax Maintenance Therapy Can Decrease the Relapse after Allogeneic Stem Cell Transplantation for MRD Positive High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Yunxiong Wei, Yaqing Cao, Xin Jin, Xiaoyuan He, Rui Sun, Xia Xiong, Wenyi Lu, MD, Xin Li, Xia Xiao, MD, Hairong Lyu, Mingfeng Zhao, MDPhD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-140359

Published: 2020

Journal Articles

CD19-CAR T Cells Treatment for Minimal Residual Disease in B-Cell Lymphoma with a Higher Response Rate and Fewer Adverse Reactions

Xia Xiao, MD, Yanyu Jiang, Xiaoyuan He, Xin Jin, Cao Yaqing, Sui Tao, Yuan Ting, Mingfeng Zhao, MD PhD

Blood (2018) 132 (Supplement 1): 3714.

https://doi.org/10.1182/blood-2018-99-114934

Published: 2018

Journal Articles

A Potential Mechanism for the Antioxidant Compound Kushen Injection Targeting the ROS Signaling Pathway in Acute Myeloid Leukemia

Yanxia Jin, PhD, Qian Yang, Li Liang, Lu Ding, Yuxing Liang, Dongdong Zhang, Tian Yang, Mingfeng Zhao, MD PhD, Fuling Zhou

Blood (2018) 132 (Supplement 1): 5221.

https://doi.org/10.1182/blood-2018-99-114066

Published: 2018

Journal Articles

Analysis of Differential Circrnas Expression Profile Identifies Novel Biomarkers for Acute Monocytic Leukemia

Balu Wu, Sr., MD, Yunbao Pan, Sr., Yanxia Jin, PhD, Mingfeng Zhao, MD PhD, Fuling Zhou, MD

Blood (2018) 132 (Supplement 1): 4948.

https://doi.org/10.1182/blood-2018-99-116399

Published: 2018

Journal Articles

Combined CCR5 and CXCR3 Blockade Attenuates Murine Agvhd through Alternating Donor-Derived T Cell Distribution and Function

Bo Tang, MD, Huihui Liu, MD, Shengchao Miao, Yujun Dong, MD, Wei Liu, MDPhD, Yongjin Shi, Chenchen Qin, Zhenhua Wang, Mingfeng Zhao, MDPhD, Hanyun Ren, MDPhD

Blood (2017) 130 (Supplement 1): 5449.

https://doi.org/10.1182/blood.V130.Suppl_1.5449.5449

Published: 2017

Journal Articles

Chromosome Aberrations Detected By SNP Array Technique Indicating a High Risk of MDS Transformation in Patients with Icus and Poor Prognosis of Patients with MDS

Xia Xiao, MD, Mingfeng Zhao, MDPhD

Blood (2017) 130 (Supplement 1): 2985.

https://doi.org/10.1182/blood.V130.Suppl_1.2985.2985

Published: 2017

NARROW

Distribution of Infectious Complications Following CLL1 CAR-T Cell Therapy for R/R AML: A Single-Center Experience

Development of ThisCART371 Targeting CLL1 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Efficacy and Safety of CAR-T Therapy Targeting CLL1 in Patients with Extramedullary Diseases of Acute Myeloid Leukemia

Variables Associated with Outcomes in Patients with Chronic Neutrophilic Leukemia with CSF3R T618I : A Multi-Centre Retrospective Study

Modified Dual CLL1-CD15 and CLL1-CD16 Icar-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia

CD19 CAR-T Therapy for Patients with Relapsed or Refractory Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study

Oncolytic Herpes Simplex Virus-Loaded CD19 CAR-T Cells Improves the Therapeutic Effect of Diffuse Large B-Cell Lymphoma

Split CAR-T Cells Targeting CD312 and TIM-3 for AML to Reduce the Risk of Antigen Escape

Prophylactic or Preemptive Donor-Derived CD19 CAR-T Cell Infusion for Preventing Relapse in High-Risk B-ALL after Allogeneic Hematopoietic Stem Cell Transplantation

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Evaluating the Effectiveness of Risk Adjustment Using Dynamic Frailty Assessment in Treating Newly Diagnosed Multiple Myeloma in Elderly Patients

Efficacy Analysis of Ixazomib-Based Regimens Based on Dynamic Frailty Assessment in Elderly and Frail Patients with Newly Diagnosed Multiple Myeloma

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL

Low-Dose Decitabine Plus Venetoclax Maintenance Therapy Can Decrease the Relapse after Allogeneic Stem Cell Transplantation for MRD Positive High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

CD19-CAR T Cells Treatment for Minimal Residual Disease in B-Cell Lymphoma with a Higher Response Rate and Fewer Adverse Reactions

A Potential Mechanism for the Antioxidant Compound Kushen Injection Targeting the ROS Signaling Pathway in Acute Myeloid Leukemia

Analysis of Differential Circrnas Expression Profile Identifies Novel Biomarkers for Acute Monocytic Leukemia

Combined CCR5 and CXCR3 Blockade Attenuates Murine Agvhd through Alternating Donor-Derived T Cell Distribution and Function

Chromosome Aberrations Detected By SNP Array Technique Indicating a High Risk of MDS Transformation in Patients with Icus and Poor Prognosis of Patients with MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only